Daily O

Indian judiciary needs to keep a tight check on big pharmas

The Supreme Court recognised the right of patients to access affordable medicines over profits of big pharma companies through 'evergreening' of patents.

Legal battles make headlines when they end in a landmark judgment. Some judgments prove to be milestones due to their long-term impact on people and their lives.

Five years ago on April 1, the Supreme Court had delivered such a judgment in a patent case involving a costly cancer drug. The court had rejected

You're reading a preview, sign up to read more.

More from Daily O

Daily O4 min readPolitics
Post-coronavirus, How India Can Bounce Back
“It’s the economy, stupid," Bill Clinton famously declared during his 1992 Presidential campaign. He won, the US economy boomed, sputtered a bit, then boomed again and Clinton won a second term in 1996. Prime Minister Narendra Modi has paid full heed
Daily O4 min readPolitics
How Growth And Equity Get A Boost In Finance Minister's Economic Stimulus Package
While Finance Minister Nirmala Sitharaman’s first tranche of announcements of the fiscal stimulus for economic recovery on Wednesday has been subjected to both criticism and accolade, PM Modi’s vision with the allocation of Rs 20 lakh crore needs a b
Daily O5 min readPolitics
Why India Has To Plan A Marathon And Not A Sprint In Attracting Global Supply Chains
The Covid-19 pandemic has hit the global economy at an unprecedented scale and speed. Essential preventive measures led to the shutdown of offices, the stoppage of factory outputs, and disruption to global industries and their supply networks. Major